Assignee
EFFEPHARM SHANGHAI CO LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
3 records- 0156US2025388616A1POLYMORPHIC FORM OF REDUCED ß-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOREFFEPHARM SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 0248US2025361259A1AMORPHOUS FORM OF REDUCED ß-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOREFFEPHARM SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 0346US12570683B2Polymorphic form of reduced beta-nicotinamide mononucleotide disodium salt, and preparation method therefor and use thereofEFFEPHARM SHANGHAI CO LTD·Filed 2023·Granted Mar 10, 2026·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when EFFEPHARM SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →